Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
98 EUR | -1,01% | -.--% | +2,08% |
Omzet 2024 * | 42,81 mld. 39,75 mld. | Omzet 2025 * | 52,47 mld. 48,72 mld. | Marktkapitalisatie | 684 mld. 635 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 11,93 mld. 11,08 mld. | Nettowinst (verlies) 2025 * | 16,55 mld. 15,37 mld. | EV/omzet 2024 * | 16,5 x |
Nettoschuld 2024 * | 19,98 mld. 18,55 mld. | Nettoschuld 2025 * | 15,29 mld. 14,19 mld. | EV/omzet 2025 * | 13,3 x |
K/w-verhouding 2024 * |
56,8
x | K/w-verhouding 2025 * |
40,9
x | Werknemers | - |
Dividendrendement 2024 * |
0,68% | Dividendrendement 2025 * |
0,79% | Vrij verhandelbaar | 99,8% |
Recentste transcriptie over Eli Lilly and Company
1 dag | -1,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 01-01-96 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 01-01-01 |
Ruth Gimeno
PSD | President | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 25-01-21 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 01-04-09 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 01-01-05 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. | |
-2,71% | 159 mld. |